All the news Showing 10 of 65 articles from: Antiviral therapyGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources HBV drug Tyzeka discontinued Healio Hepatology / 11 October 2016 ContraVir Reports New CRV431 Data Highlighting Synergistic Activity with CMX157 Against Hepatitis B ContraVir press release / 12 September 2016 Hepatitis B treatment may be linked to colorectal and cervical cancer Liz Highleyman / 10 June 2016 People with hepatitis B who were treated with nucleoside/nucleotide antivirals did not have a higher rate of malignancies overall, but did show an increased incidence of colorectal and cervical cancer, underlining the ... Antiviral therapy linked to lower liver cancer and mortality in people with mild hepatitis B Liz Highleyman / 17 May 2016 Treatment with nucleoside/nucleotide antiviral therapy was associated with longer overall survival and reduced risk of developing liver cirrhosis and hepatocellular carcinoma (HCC) for hepatitis B patients with high viral load but minimal liver ... Antiviral therapy prolongs survival in immune tolerant hepatitis B patients Eurekalert Inf Dis / 15 April 2016 Treatment for chronic hepatitis B linked to increased rates of colorectal and cervical cancer EASL press release / 15 April 2016 ContraVir's CMX157 Outperforms Gilead's Tenofovir AF (TAF) Against Hepatitis B Virus in Independent Head-to-Head In-Vitro Study ContraVir press release / 30 March 2016 J&J signs deal with Chinese company for hepatitis B drug Reuters / 08 January 2016 Gilead Announces Top-Line Results From Two Phase 3 Studies Evaluating Tenofovir Alafenamide (TAF) for Patients With Chronic Hepatitis B Infection Gilead press release / 05 January 2016 Using interferon with hepatitis B antivirals raises likelihood of HBsAg loss Liz Highleyman / 15 June 2015 Treating chronic hepatitis B with tenofovir plus pegylated interferon for 48 weeks resulted in a higher rate of hepatitis B surface antigen (HBsAg) clearance than either drug taken alone, though the response rate ... ← Prev1...23456...7Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive